Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: Distinct from other populations

Multiple Sclerosis

Volumn 15, Issue 12, 2009, Pages 1422-1430

  Wu, Xiao Mu ^a   Wang, Chaodong ^a   Zhang, Kun Nan ^a   Lin, Ai Yu ^b   Kira, Jun Ichi ^c   Hu, Guo Zhu ^a   Qu, Xin Hui ^a   Xiong, Ying Qiong ^a   Cao, Wen Feng ^a   Gong, Lin Yun ^a  

^a JIANGXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Association; Haplotype; HLA DPB1; HLA DRB1; Multiple sclerosis

Indexed keywords

HLA DPB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION DIFFERENTIATION; POPULATION RISK;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DP ANTIGENS; HLA-DR ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 72749124247     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509345905     Document Type: Article

References (49)

1. Giordano M., Dalfonso S., Momigliano-Richiardi P. Genetics of multiple sclerosis. Am J Pharmacogenomics 2002 ; 2: 37-58.
2. Games ; Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 2003 ; 143: 3946.
3. Masterman T., Ligers A., Olsson T., et al. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000 ; 48: 211-219.
4. Spurkland A., Celius EG, Knutsen I., et al. The HLA-DQ (alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR (alpha 1*01, beta 1*1501) heterodimer. Tissue Antigens 1997 ; 50: 15-22.
5. Pina MA, Ara JR, Lasierra P., et al. Major histocompatibility complex class II alleles and the course and outcome of MS. Neurology 1999 ; 52: 1923-1924.
6. McDonnell GV, Mawhinney H., Graham CA, et al. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis. J Neurol Sci 1999 ; 165: 77-83.
7. Silva AM, Pereira C., Bettencourt A., et al. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese multiple sclerosis population. J Neurol Sci 2007 ; 258: 69-74.
8. Oksenberg JR, Barcellos LF, Cree BA, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004 ; 74: 160-167.
9. Stewart GJ, Teutsch SM, Castle M., et al. HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogenet 1997 ; 24: 8192.
10. Kira J., Kanai T., Nishimura Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996 ; 40: 569-574.
11. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005 ; 14: 2019-2026.
12. Celius EG, Harbo HF, Egeland T., et al. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci 2000 ; 178: 132-135.
13. Saruhan-Direskeneli G., Esin S., Baykan-Kurt B., et al. HLA-DR and-DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997 ; 55: 59-65.
14. Marrosu MG, Murru MR, Costa G., et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and-DR4 alleles. Am J Hum Genet 1997 ; 61: 45-47.
15. Weatherby SJ, Thomson W., Pepper L., et al. HLA-DRB1 and disease outcome in multiple sclerosis. J Neurol 2001 ; 248: 304-310.
16. Gorodezky C., Najera R., Rangel BE, et al. Immunogenetic profile of multiple sclerosis in Mexicans. Hum Immunol 1986 ; 16: 364-374.
17. Kira J., Yamasaki K., Horiuchi I., et al. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 1999 ; 166: 53-57.
18. Lau KK, Wong LK, Li LS, et al. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med J 2002 ; 8: 77-80.
19. Tsai CP, Yuan CL, Yu HY, et al. Multiple sclerosis in Taiwan. J Chin Med Assoc 2004 ; 67: 500-505.
20. Cheng Q., Miao L., Zhang J., et al. Clinical features of patients with multiple sclerosis from a survey in Shanghai, China. Mult Scler 2008 ; 14: 671-678.
21. Yamasaki K., Horiuchi I., Minohara M., et al. HLA-DPB1*0501- associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999 ; 122: 1689-1696.
22. Fukazawa T., Kikuchi S., Sasaki H., et al. Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele. J Neurol 2000 ; 247: 175-178.
23. Kankonkar S., Jeyanti G., Singhal BS, et al. Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India. Hum Immunol 2003 ; 64: 478-482.
24. Hawkins BR, Yu YL, Woo E., et al. No apparent association between HLA and multiple sclerosis in Southern Chinese. J Neurol Neurosurg Psychiatry 1988 ; 51: 443-445.
25. Kelly MA, Zhang Y., Penny MA, et al. Genetic susceptibility to multiple sclerosis in a Shanghai Chinese population: the role of the HLA class II genes. Hum Immunol 1995 ; 42: 203-208.
26. Zhang Y., Zhu XC, Sheng FX, et al. Association study between HLA class II gene and genes related to antigen-presenting with multiple sclerosis in Shanghai Chinese. Chinese J Microbiol Immunol 1999 ; 19: 406-409.
27. Wang K., Wang GX, Liu XZ, et al. HLA-DRB1 allelic types and susceptibility to multiple sclerosis. Chinese J Neurol 2003 ; 36: 21-24.
28. Liang J., Chu L., Xu Z., et al. Association between polymorphisms in HLA-II genes and multiple sclerosis in Guizhou Province. Chinese J Neurol 2008 ; 41: 83-86.
29. Allen M., Sandberg-Wollheim M., SjÖgren K., et al. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994 ; 39: 41-48.
30. Stewart GJ, Teutsch SM, Castle M., et al. HLA-DR, -DQA1 and -DQB1associations in Australian multiple sclerosis patients. Eur J Immunogenet 1997 ; 24: 81.
31. Jungerman M., Sanchez-Mazas A., Fichna P., et al. HLA class II DRB1, DQA1 and DQB1 polymorphisms in the Polish population from Wielkopolska. Tissue Antigens 1997 ; 49: 624-628.
32. Saruhan-Direskeneli G., Esin S., Baykan-Kurt B., et al. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997 ; 55: 59-65.
33. Rasmussen HB, Kelly MA, Clausen J. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis. Mult Scler 2001 ; 7: 91-93.
34. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 133: 227-231.
35. Weinshenker BG, Santrach P., Bissonet AS, et al. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 1998 ; 51: 742-747.
36. de la Concha EG, Arroyo R., Crusius JB, et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/ remitting multiple sclerosis. J Neuroimmunol 1997 ; 80: 172-178.
37. Versluis LF, Rozemuller E., Duran K., et al. Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles. Tissue Antigens 1995 ; 46: 345-349.
38. International Immunogenetics database (report version 2.22) ftp://ftp.ebi.ac.uk/pub/databases/imgt/mhc/hla/ (accessed July 2008 )
39. Guo S., Thompson E. Performing the exact test of Hardy- Weinberg proportion for multiple alleles. Biometrics 1992 ; 48: 361-372.
40. Lewontin RC The interactions of selection and linkage. Genetics 1964 ; 49: 49-67.
41. Payami H., Nadir SJ, Farid R., et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989 ; 45: 541-546.
42. Dekker JW, Easteal S., Jakobsen IB, et al. HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1*0602 allele. Tissue Antigens 1993 ; 41: 31-36.
43. Teutsch SM, Bennetts BH, Buhler MM, et al. The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients. Hum Immunol 1999 ; 60: 715-722.
44. Kelly MA, Jacobs KH, Penny MA, et al. An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin. Tissue Antigens 1995 ; 45: 197-202.
45. Wongsurawat T., Nakkuntod J., Charoenwongse P., et al. The association between HLA class II haplotype with Graves disease in Thai population. Tissue Antigens 2006 ; 67: 79-83.
46. Park MH, Park YJ, Song EY, et al. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol 2005 ; 66: 741-747.
47. Huang JL, Shaw CK, Lee A., et al. HLA-DRB1 antigens in Taiwanese patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 2001 ; 21: 103-105.
48. Onuma H., Ota M., Sugenoya A., et al. Association of HLA-DPB1*0501 with early-onset Graves disease in Japanese. Hum Immunol 1994 ; 39: 195-201.
49. Chikuba N., Akazawa S., Yamaguchi Y., et al. Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese - class II antigen and autoimmune thyroid disease. Diabetes Res Clin Pract 1995 ; 27: 31-37.